Super Viagra
Super Viagra Price range: $ 96,00 through $ 495,00
Back to products
Suprax
Suprax Price range: $ 44,00 through $ 338,00

Super Zhewitra

Price range: $ 55,00 through $ 132,00

Super Zhewitra is a high-performance oral medication designed to effectively address common male sexual health concerns. This potent formula combines Vardenafil and Dapoxetine to provide a dual-action solution for both erectile dysfunction and premature ejaculation. The Vardenafil component works by increasing blood flow to the pelvic region, helping men achieve and maintain a firm erection. Simultaneously, Dapoxetine helps in extending the duration of sexual activity by providing better control over the timing of ejaculation. By targeting two issues at once, Super Zhewitra enhances overall performance and restores confidence for a more satisfying intimate experience.

Active substance: Dapoxetine, Vardenafil
SKU: Super Zhewitra Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Super Zhewitra belongs to a class of combination pharmacological agents designed to address dual aspects of male sexual dysfunction. The formulation incorporates a phosphodiesterase type 5 (PDE5) inhibitor, vardenafil, alongside a selective serotonin reuptake inhibitor (SSRI), dapoxetine. In the United States, this combination product is subject to strict regulatory oversight and is dispensed in accordance with applicable federal and state regulations governing prescription-only compounds and unapproved combination agents.

The combination of active components targets both erectile physiology and ejaculatory latency through distinct central and peripheral biochemical pathways. Patients must undergo evaluation by a qualified medical provider prior to considering therapy with combination sexual health agents.

Parameter Details
Active ingredients Vardenafil hydrochloride, Dapoxetine hydrochloride
Primary purpose Dual management of erectile dysfunction and premature ejaculation
Dosage form Oral tablet
Route of administration Oral
Prescription status Dispensed in accordance with applicable federal and state regulations
Storage Store at 20°C to 25°C (68°F to 77°F)

General Overview and Pharmacological Profile

What It’s Used For

Super Zhewitra is formulated for the symptomatic treatment of concurrent male sexual health conditions, specifically erectile dysfunction (ED) and premature ejaculation (PE). Vardenafil is indicated for improving erectile response by facilitating penile arterial blood flow during sexual stimulation. Dapoxetine is designed to increase intravascular serotonin transport and delay the ejaculatory reflex during intimate activity. The simultaneous management of both physiological conditions is intended for adult men who experience dual symptoms. It should be noted that dapoxetine is not approved by the U.S. Food and Drug Administration (FDA) as an individual entity or in combination products within the United States. Therefore, clinical use of this combination product remains non-standard under federal regulatory frameworks and requires direct physician oversight.

How the Drug Works

The therapeutic effect of Super Zhewitra relies on two distinct mechanisms of action operating in tandem. Vardenafil functions as a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). By inhibiting the degradation of cGMP in the cavernous smooth muscle cells, vardenafil enhances nitric oxide-mediated vasodilation, resulting in increased blood inflow to the erectile tissue. Dapoxetine functions as a short-acting selective serotonin reuptake inhibitor (SSRI). It inhibits the neuronal reuptake of serotonin (5-HT) in the central nervous system, thereby enhancing serotonergic neurotransmission within the neural pathways that regulate the ejaculatory reflex. Together, these mechanisms support penile rigidity while extending the time to ejaculation.

Mechanism and Pharmacokinetics

How It’s Absorbed and Eliminated

Following oral administration, both active components undergo rapid gastrointestinal absorption. Vardenafil reaches peak plasma concentrations (Cmax) within 30 to 120 minutes under fasted conditions, with an absolute oral bioavailability of approximately 15% due to extensive first-pass hepatic metabolism via the cytochrome P450 (CYP) 3A4 enzyme system. The terminal elimination half-life of vardenafil is approximately 4 to 5 hours, primarily excreted as metabolites in the feces (approximately 79%) and urine (approximately 13%). Dapoxetine is rapidly absorbed, achieving peak plasma levels within 1 to 2 hours after ingestion. Dapoxetine exhibits an initial distribution half-life of 1.2 to 1.4 hours and a terminal elimination half-life of approximately 19 hours following clearance, primarily metabolized by hepatic CYP2D6 and CYP3A4 pathways prior to urinary excretion.

Dosing and Administration Guidelines

Dosing Schedule

Administration of Super Zhewitra must be strictly individualized under professional medical supervision. The typical formulation contains 20 mg of vardenafil and 60 mg of dapoxetine per single oral tablet. The tablet is intended for oral administration with a full glass of water approximately 60 to 120 minutes prior to anticipated sexual activity. Super Zhewitra should not be taken more than once within a 24-hour period. Dosing adjustment may be required in individuals with mild to moderate hepatic or renal impairment, whereas severe hepatic impairment or end-stage renal disease requiring hemodialysis represents a formal contraindication. The tablet must be swallowed whole without chewing or crushing.

What to Avoid While Taking It

Co-administration of Super Zhewitra with high-fat meals can delay the gastrointestinal absorption of vardenafil, prolonging the time required to achieve peak plasma concentration and therapeutic efficacy. Grapefruit juice must be avoided because it inhibits hepatic CYP3A4 enzymes, potentially leading to elevated plasma concentrations of both vardenafil and dapoxetine and increasing the risk of adverse reaction onset. Ethanol consumption should be strictly avoided. Combining alcohol with dapoxetine increases the frequency and severity of neurocardiogenic adverse effects, such as syncope, orthostatic hypotension, severe dizziness, and altered mental status.

If You Skip a Dose

Super Zhewitra is administered strictly on an as-needed (PRN) basis prior to intended sexual intercourse and is not intended for continuous daily scheduling. Consequently, missing a dose is not clinically applicable in a standard daily dosing context. Patients should never double a dose or take extra tablets to compensate for a missed intended timing. Taking more than one dose in a 24-hour period significantly escalates the risk of severe cardiovascular and neurological toxicity.

Storage and Expiration

Super Zhewitra tablets should be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). Store the medication in its original blister packaging to protect the contents from moisture, excessive humidity, and direct sunlight exposure. Keep the drug out of reach and out of sight of children and pets. Do not use the medication beyond the expiration date stamped on the packaging, and dispose of unused products via safe medication take-back programs in accordance with local regulations.

Safety Information and Clinical Usage

Contraindications and Drug Interactions

What Not to Combine

Super Zhewitra exhibits severe, life-threatening pharmacodynamic interactions with organic nitrates (e.g., nitroglycerin, isosorbide mononitrate) and nitric oxide donors, causing profound systemic hypotension; concurrent administration is strictly contraindicated. Co-administration with alpha-blockers used for hypertension or benign prostatic hyperplasia can induce additive vasodilation leading to symptomatic hypotension. Furthermore, because dapoxetine is an SSRI, combination with monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, or other serotonergic agents (such as tramadol or St. John’s Wort) poses a critical risk of Serotonin Syndrome. Potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) significantly elevate plasma concentrations of both active agents.

Adverse Reactions

Clinical side effects associated with Super Zhewitra stem from the pharmacological profiles of both vardenafil and dapoxetine. Common adverse reactions involving the central nervous system include headache, dizziness, somnolence, insomnia, and fatigue. Gastrointestinal symptoms frequently reported include nausea, dyspepsia, abdominal discomfort, diarrhea, and dry mouth. Vascular reactions such as facial flushing, nasal congestion, and transient blood pressure fluctuations may occur due to PDE5 inhibition. Less common but significant reactions include visual disturbances (e.g., altered color perception or photophobia), tinnitus, syncope, orthostatic dizziness, and excessive diaphoresis. Patients experiencing persistent or distressing side effects should notify their healthcare provider.

Red Flags

Immediate emergency medical evaluation is necessary if any of the following acute reactions occur:

  • Chest pain, sudden hypotension, or severe cardiac arrhythmia
  • Priapism (a prolonged, painful erection lasting longer than 4 hours)
  • Sudden decrease or total loss of vision in one or both eyes (potential Non-Arteritic Anterior Ischemic Optic Neuropathy)
  • Sudden hearing loss or severe inner ear ringing (tinnitus)
  • Symptoms of Serotonin Syndrome, including hyperthermia, agitation, neuromuscular tremors, and severe confusion
  • Syncope (fainting) or severe orthostatic collapse

Before You Take It

Patients with pre-existing cardiovascular conditions–including recent myocardial infarction, unstable angina, severe heart failure, or uncontrolled hypertension–must avoid using Super Zhewitra due to the cardiac demands of sexual exertion coupled with systemic vasodilatory effects. The presence of psychiatric conditions such as major depressive disorder or a history of mania requires extreme caution, as dapoxetine can alter mood stability and increase syncope risk. Super Zhewitra is explicitly indicated for adult males and is not indicated for use in female patients. Safety and efficacy have not been established in pediatric populations under 18 years of age. Geriatric patients (aged 65 years and older) may exhibit reduced clearance of both vardenafil and dapoxetine, necessitating lower starting doses and rigorous medical monitoring to prevent adverse systemic events.

Frequently Asked Questions

Can Super Zhewitra be taken with blood pressure medications?

Combining Super Zhewitra with antihypertensive medications can produce additive blood pressure lowering effects. Co-administration with alpha-blockers requires stabilization on antihypertensive therapy prior to initiating treatment, and doses must be monitored closely by a healthcare professional to avoid orthostatic hypotension.

How long does the combined pharmacological effect last in the body?

The visual and physiological effects mediated by vardenafil typically diminish within 4 to 5 hours post-ingestion as plasma levels decline. Dapoxetine’s primary therapeutic duration for ejaculatory delay spans approximately 1 to 3 hours post-peak concentration, although metabolic elimination continues over 19 hours.

What should a patient do if they experience dizziness after taking a tablet?

If dizziness or lightheadedness develops, the patient should immediately lie down flat or sit with their head placed between their knees until symptoms resolve. Abruptly standing up should be avoided, and medical guidance should be sought prior to taking any subsequent doses.

Is it permissible to split or crush the Super Zhewitra tablet?

Super Zhewitra tablets are formulated for whole oral ingestion. Splitting, crushing, or chewing the film-coated tablet can alter the rate of drug absorption, potentially causing erratic drug concentrations and increasing the likelihood of gastrointestinal or systemic adverse events.

Does Super Zhewitra protect against sexually transmitted infections?

No. Super Zhewitra has no antimicrobial or antiviral properties and provides zero protection against sexually transmitted infections (STIs), including HIV. Patients must utilize appropriate barrier contraceptive methods for STI prevention.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

20mg+60mg

Package

20 pills

,

30 pills

,

60 pills

Ενεργός Ουσία

,